Briefing: Snail-derived compound could be a safer anticoagulant compared to heparin
Strategic angle: A new study suggests a snail-derived compound may reduce the risk of excessive bleeding associated with traditional anticoagulants.
Browse the full archive, newest first.
Strategic angle: A new study suggests a snail-derived compound may reduce the risk of excessive bleeding associated with traditional anticoagulants.
Strategic angle: The team is certainly hoping to continue its success after winning the Rolex 24 at Daytona in January.
Strategic angle: The Duster returns to India with premium tech and a hybrid option, but skips the AWD found in global models.
Strategic angle: Nutanix's stock price declined after the company revised its financial outlook for 2026.
Strategic angle: Johnson & Johnson's new daily psoriasis pill offers benefits comparable to injectable treatments, potentially disrupting a multibillion-dollar market.
Strategic angle: Mortgage rates shot higher last week, as the war with Iran stoked fears over inflation, leading to a significant drop in refinance demand.
Strategic angle: New research reveals the complex causes behind the resurgence of illegal fishing in northern Australian waters.
Strategic angle: Exploring the metrics and methodologies for assessing advancements in artificial general intelligence.
Strategic angle: A new study reveals how quantum communication systems can maintain functionality despite thermal disruptions.
Strategic angle: Exploring the integration of live sports data with Google AI technology.